We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRRA
1401
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.67M | ﹤0.01% |
+2,038
| New | +$2.3M |
|
|
SUNE
1402
DELISTED
SUNEDISON, INC COM
SUNE
| $1.66M | ﹤0.01% |
231,227
+192,710
| +500% | +$3.45M |
|
1403
Blackbaud
BLKB
$1.65B
| $1.66M | ﹤0.01% |
29,506
-1,018
| -3% | -$59.6K |
|
|
RDC
1404
DELISTED
Rowan Companies Plc
RDC
| $1.66M | ﹤0.01% |
102,515
+9,658
| +10% | +$168K |
|
|
USCR
1405
DELISTED
U S Concrete, Inc.
USCR
| $1.65M | ﹤0.01% |
34,562
+25,270
| +272% | +$1.19M |
|
1406
Keysight
KEYS
$52.2B
| $1.65M | ﹤0.01% |
53,414
+13,418
| +34% | +$418K |
|
|
MPT
1407
Medical Properties Trust
MPT
$2.89B
| $1.63M | ﹤0.01% |
147,634
+10,944
| +8% | +$136K |
|
1408
Pediatrix Medical
MD
$2.21B
| $1.63M | ﹤0.01% |
21,236
+6,824
| +47% | +$551K |
|
1409
Avient
AVNT
$3.41B
| $1.63M | ﹤0.01% |
55,379
-2,821
| -5% | -$95.3K |
|
1410
Dana Inc
DAN
$2.95B
| $1.62M | ﹤0.01% |
102,005
-4,356
| -4% | -$78.7K |
|
1411
PRA Group
PRAA
$688M
| $1.61M | ﹤0.01% |
30,502
-1,359
| -4% | -$78.9K |
|
1412
Louisiana-Pacific
LPX
$5.35B
| $1.61M | ﹤0.01% |
113,148
-623
| -0.5% | -$9.89K |
|
1413
Ciena
CIEN
$49.6B
| $1.61M | ﹤0.01% |
77,631
+837
| +1% | +$19.5K |
|
1414
HEICO Corp Class A
HEI.A
$36.8B
| $1.61M | ﹤0.01% |
69,199
+14,937
| +28% | +$350K |
|
1415
Woodward
WWD
$24.5B
| $1.6M | ﹤0.01% |
39,397
-1,786
| -4% | -$84.5K |
|
1416
Helen of Troy
HELE
$672M
| $1.6M | ﹤0.01% |
17,928
-487
| -3% | -$43.6K |
|
1417
Sinclair Inc
SBGI
$1.02B
| $1.6M | ﹤0.01% |
63,214
-1,979
| -3% | -$54.6K |
|
1418
Texas Roadhouse
TXRH
$13.5B
| $1.6M | ﹤0.01% |
42,973
-1,633
| -4% | -$61.7K |
|
|
SBNY
1419
DELISTED
Signature Bank
SBNY
| $1.59M | ﹤0.01% |
11,562
+3,987
| +53% | +$563K |
|
|
SYA
1420
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $1.59M | ﹤0.01% |
50,209
-1,277
| -2% | -$36.5K |
|
|
MDCO
1421
DELISTED
Medicines Co
MDCO
| $1.58M | ﹤0.01% |
41,686
-1,968
| -5% | -$69.1K |
|
|
MFLX
1422
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $1.58M | ﹤0.01% |
94,683
+15,581
| +20% | +$271K |
|
|
STMP
1423
DELISTED
Stamps.com, Inc.
STMP
| $1.58M | ﹤0.01% |
21,365
+11,676
| +121% | +$906K |
|
|
PGND
1424
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| $1.58M | ﹤0.01% |
53,342
+48,086
| +915% | +$1.46M |
|
1425
Seacoast Banking Corp of Florida
SBCF
$3.27B
| $1.57M | ﹤0.01% |
107,028
+89,269
| +503% | +$1.37M |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.